Answers are grounded in this paper and cite their sources.
Brain metastases (BMs) require accurate delineation for treatment planning, yet magnetic resonance imaging (MRI) acquisition protocols vary substantially in clinical practice. Such protocol-level heterogeneity may affect the generalizability of deep learning-based segmentation models. This study evaluated the impact of heterogeneous T1-weighted MRI protocols on BM segmentation performance using two three-dimensional architectures, 3D Attention U-Net and DUCK-Net 3D. A retrospective dataset of 925 contrast-enhanced T1-weighted MRI studies from 720 patients was analyzed. Models were trained under six sequence configurations, including multi-sequence, Black-Blood (BB), Non-Black-Blood (Non-BB), and three single-sequence cohorts. Independent test datasets consisted of three MRI cohorts: MPR Range, MPR Thick Range, and T1 SPACE 3D. Five-fold cross-validation was performed. Performance was evaluated using the Dice similarity coefficient (DSC), volumetric regression, and false discovery rate-corrected statistical comparisons. DUCK-Net 3D demonstrated more consistent performance across independent MRI cohorts, particularly under cross-sequence conditions. Multi-sequence training achieved the most stable cross-sequence performance, whereas single-sequence models showed greater sensitivity to protocol variability. Segmentation accuracy declined for small lesions (<0.4 mL) across both architectures. These findings suggest that MRI protocol heterogeneity affects segmentation performance and that sequence-diverse training may improve cross-sequence robustness in clinical settings.
No takes yet. Share an insight, caveat, or question.
Shin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: